A Woman’s Guide to Peptide Therapy
The short answer: “peptide therapy” covers different substances with very different evidence and uses. GLP-1 medicines and GHK-Cu are peptides; NAD+ and B12 are not. Start with the exact product, what’s known about it, and a provider’s assessment—not a shopping cart of vials.

Peptide therapy sounds like one thing. It is actually a broad label that includes established prescription medicines and products with much less human evidence. Before you choose a treatment, start with the exact ingredient, what you want it to help with, and what is known about that use.
Peptide therapy, in plain English
Peptides are short chains of amino acids. Your body naturally uses many peptides as signals, and medicine has learned to use or adapt some of those signals for specific health conditions. Insulin is a familiar peptide medicine. Semaglutide and tirzepatide are also peptide-based medicines, although they work differently from the recovery and longevity peptides often discussed online.
The important distinction is product-specific. FDA approval applies to an exact drug, formulation, route, dose, and use supported by evidence reviewed by the agency. It does not carry over to every product that shares a peptide label or a similar-sounding ingredient.
- Approved peptide medicines have reviewed labeling for specific uses
- Off-label prescribing involves an approved drug used for a different clinical purpose
- Compounded drugs are not FDA-approved and are not generic versions of approved drugs
- Investigational substances may have laboratory or animal data without reliable human outcomes
What the experience can look like
A good first visit should feel more like a health conversation than a product quiz. A clinician may ask what you want to improve, when the change began, what you have already tried, and whether sleep, nutrition, movement, stress, hormones, medications, or another condition could be contributing.
If a treatment is appropriate, the plan should name the exact medication, its regulatory status, how it is used, what follow-up is included, and how progress will be evaluated. Sometimes the best outcome of a visit is a different recommendation, more information, or a decision to wait.
Four categories that should not be blurred together
FDA-approved, off-label, compounded, and investigational are different regulatory and evidence categories. The table below keeps the distinction visible before any product decision.
| Category | What it means | What to verify |
|---|---|---|
| FDA-approved | Reviewed for a specific product, route, dose, and use | Approved indication and current labeling |
| Off-label | An approved drug prescribed for a different use | Evidence, rationale, and monitoring plan |
| Compounded | Prepared for an identified patient need; not FDA-approved | Pharmacy, ingredients, concentration, and instructions |
| Investigational | Still being studied and not established as approved care | Human evidence, trial status, and known uncertainties |
Who might discuss peptide-based care with a clinician
Women may bring up peptide medicines when discussing metabolic health, an FDA-approved indication, or another clearly defined clinical goal. The conversation is especially useful when marketing language has made the options feel interchangeable.
Your clinician needs the full picture: pregnancy or breastfeeding plans, personal and family history, gallbladder or pancreatic concerns, endocrine conditions, allergies, current prescriptions and supplements, and any history that changes the risk profile of the exact medicine. Eligibility is never determined by a quiz score alone.
Practical support around treatment
Medication does not replace the basics that help you feel steady. Regular meals that fit your appetite, enough fluids, protein and fiber, sleep, and movement can all support day-to-day wellbeing. The right plan is personal: someone beginning a metabolic medicine may need different support from someone using a topical skin product.
Choose one or two measures that reflect the actual goal, such as energy through the afternoon, strength, waist measurement, symptom frequency, or a clinician-selected lab value. That gives follow-up visits something more meaningful to discuss than a vague promise to feel optimized.
A calm safety and eligibility check
Safety depends on the exact substance, route, formulation, dose, and person. Ask whether the product is FDA-approved for the proposed use, whether it is being prescribed off label, compounded for a patient-specific need, or remains investigational.
Compounded drugs can meet an important individual need, but FDA does not review them before marketing for safety, effectiveness, or quality. For several wellness-marketed peptides, FDA has also identified limited safety information or quality concerns. A clinician should explain those distinctions clearly and document why the proposed option is appropriate.
Explore related care
Explore related care
Real answers. Pretty clear.
Frequently asked questions
Are all peptide therapies FDA-approved?
No. Some peptide medicines are FDA-approved for specific indications. Other uses may be off label, compounded, or investigational. Ask about the status of the exact product and proposed use.
Does natural mean lower risk?
No. A molecule can resemble something made by the body and still have meaningful effects, side effects, interactions, or manufacturing concerns.
I feel off lately. How do I know what kind of care I need?
Start with your symptoms rather than a product. Tell your clinician about changes in energy, sleep, periods, or weight, and when they began. They can assess possible causes and whether testing or a different kind of care makes sense.
What should I bring to a peptide consultation?
Bring your medication and supplement list, allergies, relevant diagnoses, pregnancy plans, recent labs if available, and the exact name or link for any product you are considering.
I avoid photos because of how I look — will treatment change that?
Many women describe confidence returning as health habits stabilize — but no medication guarantees how you'll feel about yourself. Sustainable routines, not just the scale, tend to drive the shift. Be patient with the process and lean on support that isn't appearance-based.
Medical sources
- 01Compounding and the FDA: Questions and AnswersU.S. Food and Drug Administration · 2025
- 02Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety RisksU.S. Food and Drug Administration · 2026
- 03Therapeutic peptides: historical perspectives, current development trends, and future directionsBioorganic & Medicinal Chemistry · 2018
- 04Therapeutic Peptides in Aesthetic, Metabolic and Regenerative MedicinePubMed · 2026
- 05NIH Office of Dietary Supplements: vitamin B12
- 06Grant et al.: NAD+ metabolism
Keep reading
Related reads

Weight
Semaglutide vs. Tirzepatide
A practical comparison of two weekly medicines, including how they work, what studies can tell us, and how a clinician helps choose between them.

Energy
NAD+ and Everyday Energy
What NAD+ does in the body, what human research can and cannot show, and how to approach an energy conversation without miracle claims.

Weight
The 2026 Consumer Guide to Comparing Online GLP-1 Care
A neutral guide to comparing total cost, clinical support, treatment formats, refills, and cancellation terms.
Pretty Anonymous
Questions people are asking
Explore Pretty Anonymous →Treatment requires clinician evaluation. Education does not establish eligibility or guarantee a prescription.
